Birdwatch Note
2023-11-24 15:50:06 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
COVID vaccines are not a dangerous failure. COVID vaccines have a reassuring safety profile & reduce COVID hospitalization and death. McCullough's treatment protocol has no proven efficacy in humans. Ivermectin and Hydroxychloroquine have no efficacy to treat COVID. https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00345-0/fulltext https://www.sciencedirect.com/science/article/pii/S1477893921001769 https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015017.pub3/full
Written by F735563C1D6CACAE98B239A5BF3B6B29334E5A32093D655B66C4A4A96408409D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1728051709065236888
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1728078548697583718
- noteId - 1728078548697583718
- participantId -
- noteAuthorParticipantId - F735563C1D6CACAE98B239A5BF3B6B29334E5A32093D655B66C4A4A96408409D Participant Details
- createdAtMillis - 1700841006812
- tweetId - 1728051709065236888
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- COVID vaccines are not a dangerous failure. COVID vaccines have a reassuring safety profile & reduce COVID hospitalization and death. McCullough's treatment protocol has no proven efficacy in humans. Ivermectin and Hydroxychloroquine have no efficacy to treat COVID. https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00345-0/fulltext https://www.sciencedirect.com/science/article/pii/S1477893921001769 https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015017.pub3/full
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2023-11-24 15:50:06 UTC (1700841006812) |
1969-12-31 23:59:59 UTC (-1) |
2023-11-25 04:30:11 UTC (1700886611750) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
rated at | rated by | |
2023-11-24 19:04:45 -0600 | Rating Details | |
2023-11-24 17:59:12 -0600 | Rating Details | |
2023-11-24 16:43:16 -0600 | Rating Details | |
2023-11-24 16:22:34 -0600 | Rating Details | |
2023-11-24 14:01:50 -0600 | Rating Details | |
2023-11-24 13:41:07 -0600 | Rating Details | |
2023-11-24 13:33:08 -0600 | Rating Details | |
2023-11-24 12:55:38 -0600 | Rating Details | |
2023-11-24 12:24:02 -0600 | Rating Details | |
2023-11-24 12:21:30 -0600 | Rating Details | |
2023-11-24 12:15:09 -0600 | Rating Details | |
2023-11-24 12:12:23 -0600 | Rating Details | |
2023-11-24 11:50:40 -0600 | Rating Details | |
2023-11-24 11:47:09 -0600 | Rating Details | |
2023-11-24 11:25:18 -0600 | Rating Details | |
2023-11-24 11:24:35 -0600 | Rating Details | |
2023-11-24 11:20:07 -0600 | Rating Details | |
2023-11-24 11:06:11 -0600 | Rating Details | |
2023-11-24 10:54:51 -0600 | Rating Details | |
2023-11-24 10:50:46 -0600 | Rating Details | |
2023-11-24 10:32:07 -0600 | Rating Details | |
2023-11-24 10:22:34 -0600 | Rating Details | |
2023-11-24 10:20:15 -0600 | Rating Details | |
2023-11-24 10:18:48 -0600 | Rating Details | |
2023-11-24 10:18:41 -0600 | Rating Details | |
2023-11-24 10:14:47 -0600 | Rating Details | |
2023-11-24 10:14:28 -0600 | Rating Details | |
2023-11-24 10:14:02 -0600 | Rating Details | |
2023-11-24 10:13:06 -0600 | Rating Details | |
2023-11-24 10:09:15 -0600 | Rating Details | |
2023-11-24 10:06:34 -0600 | Rating Details | |
2023-11-24 10:02:11 -0600 | Rating Details | |
2023-11-24 09:58:46 -0600 | Rating Details | |
2023-11-24 09:57:01 -0600 | Rating Details | |
2023-11-24 09:56:38 -0600 | Rating Details | |
2023-11-24 09:55:59 -0600 | Rating Details | |
2023-11-24 09:55:55 -0600 | Rating Details | |
2023-11-24 09:53:06 -0600 | Rating Details | |
2023-11-24 09:52:44 -0600 | Rating Details | |
2023-11-24 09:52:08 -0600 | Rating Details | |
2023-11-25 18:19:33 -0600 | Rating Details | |
2023-11-25 18:06:06 -0600 | Rating Details | |
2023-11-25 11:22:45 -0600 | Rating Details | |
2023-11-25 11:11:47 -0600 | Rating Details | |
2023-11-25 06:27:41 -0600 | Rating Details | |
2023-11-26 07:29:53 -0600 | Rating Details | |
2023-11-25 20:11:26 -0600 | Rating Details | |
2023-11-25 20:03:39 -0600 | Rating Details | |
2023-11-25 17:50:25 -0600 | Rating Details | |
2023-11-25 02:53:03 -0600 | Rating Details | |
2023-11-25 01:13:08 -0600 | Rating Details | |
2023-11-24 18:10:50 -0600 | Rating Details | |
2023-11-24 16:30:10 -0600 | Rating Details | |
2023-11-24 16:21:15 -0600 | Rating Details | |
2023-11-24 14:58:38 -0600 | Rating Details | |
2023-11-24 14:50:58 -0600 | Rating Details | |
2023-11-24 13:31:59 -0600 | Rating Details | |
2023-11-24 13:03:41 -0600 | Rating Details | |
2023-11-24 12:54:33 -0600 | Rating Details | |
2023-11-24 12:51:26 -0600 | Rating Details | |
2023-11-24 12:47:11 -0600 | Rating Details | |
2023-11-24 12:24:07 -0600 | Rating Details | |
2023-11-24 12:11:58 -0600 | Rating Details | |
2023-11-24 11:44:40 -0600 | Rating Details | |
2023-11-24 11:31:32 -0600 | Rating Details | |
2023-11-24 11:25:42 -0600 | Rating Details | |
2023-11-24 11:19:44 -0600 | Rating Details | |
2023-11-24 11:16:01 -0600 | Rating Details | |
2023-11-24 11:01:23 -0600 | Rating Details | |
2023-11-24 10:57:42 -0600 | Rating Details | |
2023-11-24 10:51:57 -0600 | Rating Details | |
2023-11-24 10:46:51 -0600 | Rating Details | |
2023-11-24 10:32:57 -0600 | Rating Details | |
2023-11-24 10:30:25 -0600 | Rating Details | |
2023-11-24 10:26:21 -0600 | Rating Details | |
2023-11-24 10:22:42 -0600 | Rating Details | |
2023-11-24 10:18:14 -0600 | Rating Details | |
2023-11-24 10:14:43 -0600 | Rating Details | |
2023-11-24 10:14:19 -0600 | Rating Details | |
2023-11-24 10:11:01 -0600 | Rating Details | |
2023-11-24 10:10:30 -0600 | Rating Details | |
2023-11-24 10:10:29 -0600 | Rating Details | |
2023-11-24 10:09:31 -0600 | Rating Details | |
2023-11-24 10:07:51 -0600 | Rating Details | |
2023-11-24 10:07:01 -0600 | Rating Details | |
2023-11-24 10:06:32 -0600 | Rating Details | |
2023-11-24 10:05:31 -0600 | Rating Details | |
2023-11-24 10:03:52 -0600 | Rating Details | |
2023-11-24 09:57:38 -0600 | Rating Details | |
2023-11-24 09:57:09 -0600 | Rating Details | |
2023-11-24 09:55:28 -0600 | Rating Details | |
2023-11-24 09:55:24 -0600 | Rating Details | |
2023-11-24 09:55:17 -0600 | Rating Details | |
2023-11-24 09:53:39 -0600 | Rating Details | |
2023-11-24 09:53:32 -0600 | Rating Details | |
2023-11-24 09:53:14 -0600 | Rating Details | |
2023-11-24 09:52:39 -0600 | Rating Details | |
2023-11-26 11:02:11 -0600 | Rating Details | |
2023-11-25 06:39:59 -0600 | Rating Details | |
2023-11-25 01:02:07 -0600 | Rating Details | |
2023-11-24 12:21:22 -0600 | Rating Details | |
2023-11-24 10:57:45 -0600 | Rating Details | |
2023-11-24 10:23:54 -0600 | Rating Details | |
2023-11-24 10:12:40 -0600 | Rating Details | |
2023-11-24 10:06:12 -0600 | Rating Details | |
2023-11-24 09:54:49 -0600 | Rating Details |